Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Maaike Waasdorp"'
Autor:
H. Ibrahim Korkmaz, Gwendolien Flokstra, Maaike Waasdorp, Anouk Pijpe, Stephan G. Papendorp, Evelien de Jong, Thomas Rustemeyer, Susan Gibbs, Paul P. M. van Zuijlen
Publikováno v:
Cells, Vol 12, Iss 3, p 345 (2023)
Burn injury induces a complex inflammatory response, both locally and systemically, and is not yet completely unravelled and understood. In order to enable the development of accurate treatment options, it is of paramount importance to fully understa
Externí odkaz:
https://doaj.org/article/1e8250b0edfa4169b601bb61f87a90c6
Autor:
Maaike Waasdorp, Bastiaan P. Krom, Floris J. Bikker, Paul P. M. van Zuijlen, Frank B. Niessen, Susan Gibbs
Publikováno v:
Biomolecules, Vol 11, Iss 8, p 1165 (2021)
Wound healing is an essential process to restore tissue integrity after trauma. Large skin wounds such as burns often heal with hypertrophic scarring and contractures, resulting in disfigurements and reduced joint mobility. Such adverse healing outco
Externí odkaz:
https://doaj.org/article/016dee6c10374a19b888f1c64e4f4605
Publikováno v:
Biochemistry and Biophysics Reports, Vol 10, Iss C, Pp 152-156 (2017)
Background: Protease-activated receptor-1 (PAR-1) potentiates diabetic nephropathy (DN) as evident from reduced kidney injury in diabetic PAR-1 deficient mice. Although thrombin is the prototypical PAR-1 agonist, anticoagulant treatment does not limi
Externí odkaz:
https://doaj.org/article/2269142eebfc40d99cda7074ddaeed9f
Publikováno v:
FASEB Journal, 33(10), 10966-10972. FASEB
Waasdorp, M, Florquin, S, Duitman, J & Spek, C A 2019, ' Pharmacological PAR-1 inhibition reduces blood glucose levels but does not improve kidney function in experimental type 2 diabetic nephropathy ', FASEB Journal, vol. 33, no. 10, pp. 10966-10972 . https://doi.org/10.1096/fj.201900516R
FASEB journal, 33(10), 10966-10972. FASEB
Waasdorp, M, Florquin, S, Duitman, J & Spek, C A 2019, ' Pharmacological PAR-1 inhibition reduces blood glucose levels but does not improve kidney function in experimental type 2 diabetic nephropathy ', FASEB Journal, vol. 33, no. 10, pp. 10966-10972 . https://doi.org/10.1096/fj.201900516R
FASEB journal, 33(10), 10966-10972. FASEB
Vorapaxar-dependent protease-activated receptor (PAR)-1 inhibition diminishes diabetic nephropathy in experimental type 1 diabetes. As most patients with diabetic nephropathy suffer from type 2 diabetes, the aim of this study was to investigate wheth
Publikováno v:
Journal of cellular and molecular medicine, 23. Wiley-Blackwell
Journal of cellular and molecular medicine, 23(2), 1268-1279. Wiley-Blackwell
Journal of Cellular and Molecular Medicine
Journal of cellular and molecular medicine, 23(2), 1268-1279. Wiley-Blackwell
Journal of Cellular and Molecular Medicine
End‐stage renal disease, the final stage of all chronic kidney disorders, is associated with renal fibrosis and inevitably leads to renal failure and death. Transition of tubular epithelial cells (TECs) into mesenchymal fibroblasts constitutes a pr
Autor:
Alsya J. Affandi, Tiago Carvalheiro, Andrea Ottria, Judith J. de Haan, Maike A.D. Brans, Maarten M. Brandt, Ralph G. Tieland, Ana P. Lopes, Beatriz Malvar Fernández, Cornelis P.J. Bekker, Maarten van der Linden, Maili Zimmermann, Barbara Giovannone, Catharina G.K. Wichers, Samuel Garcia, Michael de Kok, Giuseppina Stifano, Yan Juan Xu, M. Anna Kowalska, Maaike Waasdorp, Caroline Cheng, Susan Gibbs, Saskia C.A. de Jager, Joel A.G. van Roon, Timothy R.D.J. Radstake, Wioleta Marut
Publikováno v:
Cell Reports, 38(1):110189. Cell Press
Affandi, A J, Carvalheiro, T, Ottria, A, de Haan, J J, Brans, M A D, Brandt, M M, Tieland, R G, Lopes, A P, Fernandez, B M, Bekker, C P J, van der Linden, M, Zimmermann, M, Giovannone, B, Wichers, C G K, Garcia, S, de Kok, M, Stifano, G, Xu, Y J, Kowalska, M A, Waasdorp, M, Cheng, C, Gibbs, S, de Jager, S C A, van Roon, J A G, Radstake, T R D J & Marut, W 2022, ' CXCL4 drives fibrosis by promoting several key cellular and molecular processes ', Cell Reports, vol. 38, no. 1, 110189 . https://doi.org/10.1016/j.celrep.2021.110189
Cell Reports, 38(1). Cell Press
Affandi, A J, Carvalheiro, T, Ottria, A, de Haan, J J, Brans, M A D, Brandt, M M, Tieland, R G, Lopes, A P, Fernández, B M, Bekker, C P J, van der Linden, M, Zimmermann, M, Giovannone, B, Wichers, C G K, Garcia, S, de Kok, M, Stifano, G, Xu, Y J, Kowalska, M A, Waasdorp, M, Cheng, C, Gibbs, S, de Jager, S C A, van Roon, J A G, Radstake, T R D J & Marut, W 2022, ' CXCL4 drives fibrosis by promoting several key cellular and molecular processes ', Cell Reports, vol. 38, no. 1, 110189 . https://doi.org/10.1016/j.celrep.2021.110189
Affandi, A J, Carvalheiro, T, Ottria, A, de Haan, J J, Brans, M A D, Brandt, M M, Tieland, R G, Lopes, A P, Fernandez, B M, Bekker, C P J, van der Linden, M, Zimmermann, M, Giovannone, B, Wichers, C G K, Garcia, S, de Kok, M, Stifano, G, Xu, Y J, Kowalska, M A, Waasdorp, M, Cheng, C, Gibbs, S, de Jager, S C A, van Roon, J A G, Radstake, T R D J & Marut, W 2022, ' CXCL4 drives fibrosis by promoting several key cellular and molecular processes ', Cell Reports, vol. 38, no. 1, 110189 . https://doi.org/10.1016/j.celrep.2021.110189
Cell Reports, 38(1). Cell Press
Affandi, A J, Carvalheiro, T, Ottria, A, de Haan, J J, Brans, M A D, Brandt, M M, Tieland, R G, Lopes, A P, Fernández, B M, Bekker, C P J, van der Linden, M, Zimmermann, M, Giovannone, B, Wichers, C G K, Garcia, S, de Kok, M, Stifano, G, Xu, Y J, Kowalska, M A, Waasdorp, M, Cheng, C, Gibbs, S, de Jager, S C A, van Roon, J A G, Radstake, T R D J & Marut, W 2022, ' CXCL4 drives fibrosis by promoting several key cellular and molecular processes ', Cell Reports, vol. 38, no. 1, 110189 . https://doi.org/10.1016/j.celrep.2021.110189
Fibrosis is a major cause of mortality worldwide, characterized by myofibroblast activation and excessive extracellular matrix deposition. Systemic sclerosis is a prototypic fibrotic disease in which CXCL4 is increased and strongly correlates with sk
Publikováno v:
Oncotarget
Oncotarget, 9(31), 21655-21662. Impact Journals
Oncotarget, 9(31), 21655-21662. Impact Journals
// Maaike Waasdorp 1 , JanWillem Duitman 1, 2, 3 , Sandrine Florquin 4 and C. Arnold Spek 1 1 Center for Experimental and Molecular Medicine, Academic Medical Center, Amsterdam, The Netherlands 2 Inserm UMR1152, Physiopathologie et Epidemiologie des
Autor:
Paul P. M. van Zuijlen, Susan Gibbs, Frank B. Niessen, Bastiaan P. Krom, Maaike Waasdorp, Floris J. Bikker
Publikováno v:
Waasdorp, M, Krom, B P, Bikker, F J, van Zuijlen, P P M, Niessen, F B & Gibbs, S 2021, ' The bigger picture : Why oral mucosa heals better than skin ', Biomolecules, vol. 11, no. 8, 1165 . https://doi.org/10.3390/biom11081165
Biomolecules
Biomolecules, Vol 11, Iss 1165, p 1165 (2021)
Biomolecules
Biomolecules, Vol 11, Iss 1165, p 1165 (2021)
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.Wound healing is an essential process to restore tissue integrity after trauma. Large skin wounds such as burns often heal with hypertrophic scarring and contractures, resulting in disfigureme
Publikováno v:
American journal of translational research. 10(7)
Diabetic nephropathy is a major microvascular complication of diabetes mellitus, and the leading cause of end stage renal disease worldwide. The pathogenesis of diabetic nephropathy is complex, making the development of novel treatments that stop or
Autor:
Tom van der Poll, Farhad Rezaee, Cong Lin, Keren Borensztajn, C. Arnold Spek, Maaike Waasdorp, Kun Shi
Publikováno v:
Oncotarget, 6(34), 35304-35314. Impact Journals LLC
Oncotarget, 6(34), 35304-35314. Impact Journals
Oncotarget
Oncotarget, 6(34), 35304-35314. Impact Journals
Oncotarget
Idiopathic pulmonary fibrosis (IPF) is a destructive disease in part resulting from premature or mature cellular aging. Protease-activated receptor-1 (PAR-1) recently emerged as a critical component in the context of fibrotic lung diseases. Therefore